NAD+ Injections vs Patches and Creams: What Does the Evidence Actually Show?

If you're trying to decide between an NAD+ injection and an NAD+ patch or cream, the short answer is that the evidence to date does not support patches or creams raising NAD+ levels in the body the way an injection can. NAD+ is a relatively large, charged molecule, and the research on skin penetration suggests it is unlikely to cross intact skin in meaningful amounts, whatever the marketing around a product claims. Below, we look at why the molecule's size matters, what has actually been studied, and how injections, patches and creams compare on the facts we can verify this year.

How NAD+ Injections Work

At-home NAD+ kits are typically administered as a subcutaneous or intramuscular injection, delivering the compound directly into body tissue rather than relying on it being absorbed through the skin or digested through the gut. This route bypasses two of the biggest barriers facing a topical product: the skin barrier and, for oral products, the digestive system, both of which can break down or block larger molecules before they ever reach the bloodstream. We've covered the practical differences between injection sites in more detail in our guide to

subcutaneous vs intramuscular NAD+ injections.

Why Patches and Creams Face a Molecular Size Problem

NAD+ (nicotinamide adenine dinucleotide) has a molecular weight of roughly 663 g/mol and carries a charge at physiological pH, according to its PubChem compound record. That matters because of what's sometimes called the "500 Dalton rule" in dermatology: a widely cited 2000 paper by Bos and Meinardi, published in Experimental Dermatology, found that molecules above roughly 500 Daltons generally struggle to passively cross intact human skin. Below that size, successful transdermal drug patches exist, including nicotine (about 162 Da), nitroglycerin (about 227 Da), estradiol (about 272 Da) and fentanyl (about 336 Da). NAD+, at roughly double the threshold, falls well outside that range.

It's also worth noting that NAD+ doesn't diffuse freely even inside the body: according to its PubChem record, the molecule can't cross cell membranes on its own and relies on dedicated transport proteins to move between cellular compartments. If NAD+ needs active, specialised transport to cross membranes inside the body, that's a reasonable hint that passively crossing the much tougher barrier of intact skin is, at minimum, a high bar for any patch or cream to clear.

What the Research on Topical and Patch-Based NAD+ Actually Shows

We looked for published clinical trials showing that NAD+ patches or creams raise NAD+ levels in blood or tissue, and did not find any. A broader review of transdermal wellness patches by

Science-Based Medicine reached a similar conclusion for the wellness-patch category in general: products built around larger or charged molecules (its examples included magnesium and vitamin B12) lack reliable clinical evidence of meaningful absorption, while the patches that genuinely work pharmaceutically are built around small, often fat-soluble molecules.

There is a separate, smaller body of research into topical NAD+ precursor formulations for skin-specific effects, such as antioxidant support or barrier function, which is a different question from whether a product raises systemic NAD+ levels throughout the body. Some research suggests certain precursor molecules may behave differently on the skin's surface than NAD+ itself, but this is an emerging area, and it should not be read as evidence that an NAD+ patch or cream delivers the same effect as an injection.

NAD+ Injections vs Patches vs Creams: Side-by-Side

Here's how the three delivery methods compare on the points we could verify this year. This isn't a ranking of outcomes, since the clinical evidence for NAD+ supplementation generally remains limited, but it does highlight the practical and regulatory differences between the options.

Delivery method	How it reaches the body	Published evidence of raising NAD+ levels	UK regulatory status
Subcutaneous/intramuscular injection	Delivered directly into tissue, bypassing skin and gut barriers	Some human and animal research exists on injectable and IV NAD+, though evidence remains limited overall	Unlicensed by the MHRA as a medicine; sold as a self-administered wellness product
Transdermal patch	Worn on the skin; intended to diffuse through it	We found no published clinical trials showing patches raise blood or tissue NAD+ levels	Typically sold as a wellness or cosmetic product, not a licensed medicine
Topical cream	Applied to the skin surface	We found no published trials showing creams raise systemic NAD+ levels; some separate research looks at skin-surface effects only	Typically sold as a cosmetic product

What This Means If You're Choosing a Delivery Method

If your main interest is whether a product is likely to raise NAD+ levels in the body, the evidence currently available favours injections over patches or creams, simply because injections avoid the skin-penetration problem altogether. That said, it's worth remembering that NAD+ injections themselves remain unlicensed by the MHRA in the UK, and the overall clinical evidence base for NAD+ supplementation, whatever the delivery method, is still developing. Cost is another practical factor worth weighing; we've broken down

how NAD+ pricing compares per mg across delivery formats if that's part of your decision. If you're taking any prescription medication, including GLP-1 treatments, speak with your prescriber before adding any new injectable or supplement product to your routine.

Frequently Asked Questions

Can an NAD+ patch or cream still be worth using even if it doesn't raise internal NAD+ levels?

Possibly, depending on what you're looking for. Some topical products are marketed for skin-surface benefits, such as antioxidant support, which is a separate claim from raising NAD+ levels throughout the body. If a product's claim is specifically about boosting systemic NAD+, the current lack of published evidence for patches and creams is worth factoring into that decision.

If NAD+ patches don't appear to cross the skin, why are they sold?

We can't speak to any individual brand's reasoning, but patches and creams are generally easier and cheaper to manufacture and sell than an injectable product, and they tap into general interest in NAD+ as an ingredient. That doesn't tell us whether a specific product is effective; it simply means the format exists in the market for reasons beyond demonstrated absorption.

Is a subcutaneous or intramuscular NAD+ injection likely to be more effective than a patch?

Based on the available evidence around molecular size and skin permeability, an injection is more likely to deliver NAD+ into the body than a patch or cream, since it avoids the skin barrier entirely. That said, individual response to any NAD+ product varies, and the broader clinical evidence for NAD+ supplementation is still developing regardless of delivery method.

How quickly might someone notice effects from an injection compared with a patch?

There isn't good comparative data on this, and individual experiences vary considerably. Because patches and creams face a more fundamental question about whether they reach the bloodstream at all, timing comparisons between the two formats aren't well established in published research.

Are NAD+ patches or creams regulated in the UK the same way as injectable NAD+ kits?

Not typically. Injectable NAD+ kits like ours are unlicensed by the MHRA as a medicine, while patches and creams are usually sold as wellness or cosmetic products, which generally face lighter regulatory requirements than medicines. It's worth checking a product's own labelling and any official guidance before relying on how it's categorised.

This article is for general informational purposes only and does not constitute medical advice. Always speak with a qualified healthcare professional before starting any new supplement or injectable therapy.